Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

作者：Sushil Kumar, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, J. Tobias, C. Siebel, M. A. Blanco, Andres J Klein-Szanto, Christopher Joachim Lengner, A. Welm, Yibin Kang, R. Chakrabarti · 发表于：Nature Communications · 年份：2022 · DOI：10.1038/s41467-022-30946-9 · 被引用次数：3 · 研究领域：Medicine

The original version of this Article contained an error in the legend of Fig. 7. The sentence “The alone doxorubicin group was used for both the experiments in Fig. 7a–b and 8 d, e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)” was replaced with “The alone doxorubicin and αDll1+Dox groups were used for both the experiments in Fig. 6a–b and 7d,e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)”. In the original source data file of Fig. 7b, the value for cell 4f contained a wrong number. These errors been corrected in both the PDF and HTML versions of the Article and the source data has been replaced. https://doi.org/10.1038/s41467-022-30946-9 OPEN